Leader in Antifungal R&DLeader in Antifungal R&DLeader in Antifungal R&DLeader in Antifungal R&D
Overview
R&D
Management & Board
Advisors
Scientific Services
Publications
Careers
Press Releases
Useful Links
Contact Us
Management Board
.
 

Christopher Wright, M.A. – Non Executive Director

Christopher Wright is Chairman and a co-founder of EMAlternatives LLC in Washington DC, an emerging markets focused private equity asset management firm and a director of Merifin Capital Group, a private European investment firm. [more]


Shane Kelly - Chief Executive Officer.

Shane has extensive experience in financing, operating and managing early and mid size growth companies. [more]


Richard White, Ph.D – Non Executive Director

Richard has a wealth of experience in infectious disease drug discovery. [more]


Sten Verland, Ph.D – Non Executive Director

Sten Verland is founding partner at Sunstone Capital. His primary investment focus includes drug development, vaccines and stem cells, and he has more than 20 years experience as an international executive, entrepreneur and venture investor in biotech companies as well as pre-clinical and clinical CROs. Currently, Sten also serves as non-executive chairman of Action Pharma A/S and Zymenex A/S. [more]


F2G Ltd, PO Box 1, Lankro Way, Eccles, Manchester, M30 0BH
Tel +44 (0)161 785 1270 Fax +44 (0)161 785 1273 Email contact@f2g.com